🇺🇸 ALKS — Alkermes plc

Salud Compra
← Volver

Precio actual

45,69 USD

Máx. histórico

98,06

9743 días

Split 2:1 del 15/05/2000

Caída desde máximo

-53,41%

Rango 52 semanas

27,00 – 55,67

Variación hoy

+1,78%

Cierre anterior

44,89

Rango de hoy

45,22 – 47,43

Volumen hoy

2.328.578

Peor caída histórica

-96,15%

01/03/2000 → 11/07/2002

Aún sin recuperar

Volatilidad anualizada ⓘ

61,59%

Información
Nombre completo
Alkermes plc
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
2.050
PER ⓘ
120,24 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
56,21 USD (puede no estar actualizado)
Primera cotización
16/07/1991
Precio actualizado
hace 6 horas
Sobre la empresa

Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and LUMRYZ, an extended-release oral suspension product for the treatment of cataplexy or EDS in pediatric patients. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.

Splits Registrados en el histórico de precios
Fecha Ratio
15/05/2000 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
17/01/2025 29,98 30,04 29,27 29,47 -0,94% 2,57% 1.098.400
16/01/2025 29,02 30,00 28,91 29,75 +2,41% 3,76% 2.240.200
15/01/2025 29,08 29,25 28,28 29,05 +1,93% 3,34% 1.336.500
14/01/2025 28,40 28,76 28,40 28,50 +0,53% 1,27% 1.198.800
13/01/2025 27,78 28,51 27,70 28,35 +0,96% 2,92% 1.100.700
10/01/2025 27,96 28,46 27,90 28,08 -1,20% 2,00% 1.289.200
08/01/2025 28,38 28,57 28,10 28,42 -0,42% 1,66% 1.614.000
07/01/2025 28,37 28,82 28,17 28,54 +0,25% 2,29% 1.370.100
06/01/2025 28,93 29,02 28,36 28,47 -1,96% 2,28% 1.481.200
03/01/2025 28,77 29,28 28,66 29,04 +1,01% 2,16% 1.187.700
02/01/2025 29,10 29,36 28,66 28,75 -0,03% 2,41% 1.090.300
31/12/2024 28,94 29,29 28,47 28,76 -0,07% 2,83% 1.264.400
30/12/2024 29,30 29,42 28,78 28,78 -2,61% 2,18% 1.010.800
27/12/2024 29,48 29,93 29,31 29,55 -0,87% 2,10% 844.900
26/12/2024 29,54 29,93 29,33 29,81 +0,54% 2,03% 771.400
24/12/2024 29,51 29,75 29,26 29,65 +0,51% 1,66% 417.100
23/12/2024 29,63 29,84 29,18 29,50 -0,71% 2,23% 1.337.400
20/12/2024 29,76 30,37 29,53 29,71 -0,87% 2,82% 4.636.200
19/12/2024 30,17 30,42 29,73 29,97 -0,33% 2,29% 1.457.100
18/12/2024 30,76 31,04 29,65 30,07 -2,21% 4,52% 3.001.600
17/12/2024 30,68 31,18 30,28 30,75 +0,26% 2,93% 2.272.200
16/12/2024 30,36 30,99 30,26 30,67 +0,52% 2,40% 2.337.800
13/12/2024 30,32 30,62 30,08 30,51 +0,03% 1,78% 1.483.100
12/12/2024 30,79 30,99 30,46 30,50 -1,42% 1,72% 918.300
11/12/2024 30,88 31,15 30,36 30,94 +1,11% 2,56% 1.382.600
10/12/2024 31,50 31,51 30,55 30,60 -2,27% 3,05% 1.552.600
09/12/2024 31,48 32,25 31,29 31,31 -0,48% 3,05% 1.712.100
06/12/2024 31,35 32,00 31,05 31,46 +0,87% 3,03% 1.485.700
05/12/2024 31,21 31,54 31,02 31,19 +0,42% 1,67% 1.747.900
04/12/2024 29,54 31,24 29,38 31,06 +5,36% 6,30% 1.819.200